Drugs / Mineral trioxide aggregate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05190783 Comparator | Mar 2019 → Aug 2021 | dental caries | Mansoura University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mineral trioxide aggregate | “Mineral trioxide aggregate (MTA) is a bioactive endodontic cement (BEC) mainly comprised of calcium and silicate elements.” PMID 28836288 ↗ Sep 2017 |
| Known as | MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05190783 ↗ |
| Modality | Other / unclassified | “Mineral trioxide aggregate (MTA) is a bioactive endodontic cement (BEC) mainly comprised of calcium and silicate elements.” PMID 28836288 ↗ Sep 2017 |